<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04967638</url>
  </required_header>
  <id_info>
    <org_study_id>S63615-1</org_study_id>
    <nct_id>NCT04967638</nct_id>
  </id_info>
  <brief_title>Survival Analysis of Oral Cancer Patients</brief_title>
  <official_title>Survival Analysis of Segmental Mandibulectomy With Immediate Vascularized Fibula Flap Reconstruction in Stage IV Oral Squamous Cell Carcinoma Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>KU Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>KU Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to assess the survival rate of oral squamous cell carcinoma (OSCC) patients&#xD;
      following immediate mandibular reconstruction with vascularized fibula flap (VFF) and to&#xD;
      identify risk factors influencing the overall survival rate and postoperative outcomes.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2020</start_date>
  <completion_date type="Actual">December 1, 2020</completion_date>
  <primary_completion_date type="Actual">September 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The overall cumulative survival</measure>
    <time_frame>5th year</time_frame>
    <description>The overall cumulative survival was recorded at the fifth-year.</description>
  </primary_outcome>
  <enrollment type="Actual">74</enrollment>
  <condition>Head and Neck Cancer</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>tumor resection and mandible reconstruction</intervention_name>
    <description>The patients who underwent primary ablative tumor resection with segmental mandibulectomy and immediate VFF reconstruction were retrieved from the database</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The files of patients diagnosed and treated between January 1996 to June 2019 for OSCC were&#xD;
        retrospectively reviewed. The patients who underwent primary ablative tumor resection with&#xD;
        segmental mandibulectomy and immediate VFF reconstruction were retrieved from the database&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinical diagnosis of stage IV OSCC&#xD;
&#xD;
          -  Follow-up period more than one year.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Non-neoplastic diseases&#xD;
&#xD;
          -  Two-staged reconstruction&#xD;
&#xD;
          -  Presurgical distant metastasis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 7, 2021</study_first_submitted>
  <study_first_submitted_qc>July 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 19, 2021</study_first_posted>
  <last_update_submitted>July 15, 2021</last_update_submitted>
  <last_update_submitted_qc>July 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>KU Leuven</investigator_affiliation>
    <investigator_full_name>Hongyang Ma</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <keyword>Squamous cell carcinoma</keyword>
  <keyword>Free fibula flap</keyword>
  <keyword>Prognosis</keyword>
  <keyword>Survival</keyword>
  <keyword>Mandibular reconstruction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Head and Neck Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

